2017 Volume 149 Pages 120-127
We investigated 273 patients who experienced sudden deafness and visited our hospital between 2004 and 2008. The patients received tapering courses of hydrocortisone with an initial dose of either 500 mg or 300 mg. The mean age was 51.2 years, with the largest numbers of patients in their 40s, 50s, 60s and 70s, respectively. The >60 years of age group had a significantly lower rate of treatment efficacy than the <60 years of age group. The complete recovery rates were 85.8% for grade 1, 45.1% for grade 2, 27.9% for grade 3, and 17.5% for grade 4. Once the patients’ hearing had stabilized, no significant differences in the effective rate of hearing were observed between patients who had received an initial hydrocortisone dose of 500 mg and those who had received an initial dose of 300 mg.
